Upgrade to SI Premium - Free Trial

Dyne Therapeutics Inc. (DYN)

7.60 -0.45 (5.59%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (6/30/18 *Est)

Latest Headlines

Form SC 13G Dyne Therapeutics, Inc. Filed by: Deep Track Capital, LP January 20, 2022 4:28 PM - SEC Filing Dyne Therapeutics Inc. (DYN) Announces FDA Places Clinical Hold on IND Application for DYNE-251 January 18, 2022 8:01 AM - StreetInsider Dyne Therapeutics Announces FDA Clinical Hold on IND Application for DYNE-251 in Duchenne Muscular Dystrophy January 18, 2022 8:01 AM - StreetInsider Dyne Therapeutics Announces FDA Clinical Hold on IND Application for DYNE-251 in Duchenne Muscular Dystrophy January 18, 2022 8:00 AM - Globe NewsWire Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference January 5, 2022 7:30 AM - Globe NewsWire Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference January 5, 2022 7:30 AM - StreetInsider Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: Scalzo Richard William December 14, 2021 4:24 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: McNeill Jonathan December 14, 2021 4:23 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: HIGH SUSANNA GATTI December 14, 2021 4:22 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: Farwell Wildon December 14, 2021 4:21 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: Brumm Joshua T December 14, 2021 4:20 PM - SEC Filing Form 4 Dyne Therapeutics, Inc. For: Dec 10 Filed by: Beskrovnaya Oxana December 14, 2021 4:20 PM - SEC Filing Form 8-K Dyne Therapeutics, Inc. For: Dec 02 December 3, 2021 6:02 AM - SEC Filing Dyne Therapeutics (DYN) Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for DMD December 2, 2021 8:33 AM - StreetInsider Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy December 2, 2021 8:30 AM - Globe NewsWire Dyne Therapeutics Announces Submission of IND Application to Initiate Clinical Trial of DYNE-251 for Duchenne Muscular Dystrophy December 2, 2021 8:30 AM - StreetInsider Form EFFECT Dyne Therapeutics, Inc. November 18, 2021 6:04 AM - SEC Filing Dyne Therapeutics Inc. (DYN) Files $400M Mixed Shelf November 4, 2021 9:06 AM - StreetInsider Form S-3 Dyne Therapeutics, Inc. November 4, 2021 8:55 AM - SEC Filing Form 8-K Dyne Therapeutics, Inc. For: Nov 04 November 4, 2021 7:37 AM - SEC Filing Dyne Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights November 4, 2021 7:30 AM - Globe NewsWire Dyne Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights November 4, 2021 7:30 AM - StreetInsider Form 10-Q Dyne Therapeutics, Inc. For: Sep 30 November 4, 2021 7:27 AM - SEC Filing Full Article List